Interv Akut Kardiol. 2002;1(1):13-20

Primary coronary angioplasty in the elderly

Petr Kala, Martin Poloczek, Otakar Boček, Petr Jeřábek, Petr Neugebauer, Jiřina Kosová
Interní kardiologická klinika FN a LF MU v Brně

Background: Primary PTCA is the method of choice in the reperfusion treatment of the acute ST-elevation myocardial infarction. The question is whether this treatment would be equally effective also in the elderly.

Methods: A retrospective analysis of the 116 patients indicated to the primary PTCA in 2000. The group of patients was divided into 14 patients (10,5 %) in group A aged ≥74 and in 102 younger patients in group B. Basic characteristics of the groups, primary angiographical results and the hospitalization outcome were analysed. Smoking was the only significantly different main risk factor.

Results: In groups A vs. B 8 vs. 37 patients (57,2 resp. 36,3 %) showed signs of heart failure, the average number of diseased coronary arteries was 2,44 vs. 1,94 (p = 0,009) and the temporary heart stimulation was used more often (p = 0,043). Gp IIb/IIIa blockers were administered only in 20 patients (19,6 %) of B group. The infarction related artery was initially occluded (TIMI 0–1) in 78,6 % vs. 80,4 %. The final TIMI flow 2 + 3 was achieved in 85,7 % vs. 98 % (p = 0,02), the artery was not reperfused in 14,3 % vs. 2 % of the patients. The time intervals from the symptom onset to the reperfusion were not significantly different. The in-hospital mortality was 14,3 % vs. 3,9 %, excluding the patients in cardiogenic shock the mortality rate was 8,3 % resp. 1,1 %.

Conclusion: Primary PTCA is in short-term follow-up a very effective method of reperfusion therapy even in the high-risk group of elderly patients.

Keywords: percutaneous coronary angioplasty, primary coronary angioplasty, acute myocardial infarction.

Published: December 31, 2002  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kala P, Poloczek M, Boček O, Jeřábek P, Neugebauer P, Kosová J. Primary coronary angioplasty in the elderly. Interv Akut Kardiol. 2002;1(1):13-20.
Download citation

References

  1. Newby LK, Rutsh WR, Califf RM, et al. Time from symptom onset to treatment and outcomes after thrombolytic therapy. J Am Coll Cardiol 1996;27:249-255.
  2. Den Heijer P, Vermeer F, Ambrosioni E, et al. Evaluation of a weight-adjusted single-bolus plasminogen activator in patients with myocardial infarction:a double-blind, randomized angiographic trial of lanoteplase versus alteplase. Circulation 1998;98:2117-2125. Go to original source... Go to PubMed...
  3. Francosi MG, Santoro E, De Vita C, et al. on behalf of the GISSI Investigators. Ten-year follow-up of the first megatrial testing thrombolytic therapy in patients with acute myocardial infarction:results of the Gruppo Italiano per lo Studio della Sopravivenza nell´Infarto-1 Study. Circulation 1998;98:2659-2665. Go to original source... Go to PubMed...
  4. Widimský P, Groch L, Želízko M, et al. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs. combined strategy for patients with acute myocardial infarction presenting to a community hospital without a cathetrisation laboratory. The PRAGUE study. Eur Heart J 2000;21(10):823-831. Go to original source... Go to PubMed...
  5. Antman EM, Gibson CM, de Lemos JA, et al. Combination reperfusion therapy with abciximab and reduced dose reteplase:results from TIMI 14. Eur Heart J 2000;21: 1944-1953. Go to original source... Go to PubMed...
  6. Stone GW, Brodie BR, Griffin JJ, et al. Should the risk of delaying reperfusion prohibit inter-hospital transfer to perform primary PTCA in acute myocardial infarction. Circulation 1996;94:1330.
  7. Brodie B, Studckey T, Wall T, et al. Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 1998;32:1312-1319. Go to original source... Go to PubMed...
  8. Nunn CM, O´Neill WW, Rothbaum D, et al. Long term outcome after primary angioplasty:Report from the Primary Angioplasty in Myocardial Infarction (PAMI-I) Trial. Am J Coll Cardiol 1999;33:640-646. Go to original source... Go to PubMed...
  9. Stone GW, Brodie BR, Griffin JJ, et al. Clinical and angiographic follow-up after primary stenting in acute myocardail infarction:the Primary Angioplasty in Myocardial Infarction (PAMI stent) pilot trial. Circulation 1999;99:1548-1554. Go to original source... Go to PubMed...
  10. Zijlstra F. Long-term benefit of primary angioplasty compared to thrombolytic therapy for acute myocardial infarction. Eur Heart J 2000;21:1487-1489. Go to original source... Go to PubMed...
  11. Brener SJ, Barr LA, Burchenal JE, et al. Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. Circulation 1998;98:734-741. Go to original source... Go to PubMed...
  12. Montalescot G, Barragan P, Wittenberg O, et al. Abciximab associated with primary angioplasty and stenting in acute myocardial infarction:the ADMIRAL study, 30-day results. Eur Heart J 1999;20:170.
  13. Muhlestein JB, Karagounis LA, Treehan S, et al., ,Rescue" utilization of abciximab for the dissolution of coronary thrombus developing as a complication of coronary angioplasty. J Am Coll Cardiol 1997;30:1729-1734. Go to original source... Go to PubMed...
  14. Kala P, Boček O, Jeřábek P, Semrád B. Rescue podání blokátoru destiček Gp IIb/ IIIa (Abciximab) při PTCA. Cor et Vasa 1999;41(Suppl.4):27(Abstrakt).
  15. Vojáček J, Hraboš V, Malý M, et al. Stenty, inhibitory IIb/IIIa destičkových receptorů, nebo obojí u akutního infarktu myokardu? Cor et Vasa 2001;43(10):499-502.
  16. Kala P, Jeřábek J, Boček O, Neugebauer P, Kosová J, Semrád B. Primární PTCA v léčbě akutního infarktu myokardu - zkušenosti s nonstop provozem. Cor et Vasa 2000;42(4) Suppl:30-31.
  17. Kala P, Poloczek M, Boček O, Jeřábek P, Neugebauer P, Kosová J. Implantace koronárních stentů při reperfúzní léčbě akutního infarktu myokardu. Vnitřní lékařství 2002 (v tisku).
  18. Kala P, Poloczek M, Boček O, Jeřábek P, Neugebauer P, Kosová J, et al. Gp IIb/ IIIa blokátory destiček u akutního infarktu myokardu léčeného primární koronární angioplastikou. Vnitřní lékařství 2002 (v tisku).
  19. Eagle KA, Goodman SG, Avezum A, Budaj A, Sullivan CM, López-Sendón J for the GRACE Investigators. Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction:findings from the Global Registry of Acute Coronary Events (GRACE). Lancet 2002;359:373-377. Go to original source... Go to PubMed...
  20. Mehta RS, Eikelboom JW, Yusuf S. Risk of intracranial haemorrhage with bolus versus infusion thrombolytic therapy:a meta-analysis. Lancet 2000;356:449-454. Go to original source... Go to PubMed...
  21. Cannon ChP. Multimodality reperfusion therapy for acute myocardial infarction. Am Heart J 2000;140:707-716. Go to original source... Go to PubMed...
  22. Beohar N, Davidson ChJ, Weigold G, Goodreau L, Benzuly KH, Bonow RO et al. Predictors of Long-Term Outcomes Following Direct Percutaneous Coronary Intervention for Acute Myocardial Infarction. Am J Cardiol 2001;88:1103-1107. Go to original source... Go to PubMed...
  23. Brodie RB, Stone GW, Morice M-C, Cox DA, Garcia E, Mattos LA, et al. Importance of Time to Reperfusion on Oucomes With Primary Coronary Angioplasty fow Acute Myocardial Infarction (Results from the Stent Primary Angioplasty in Myocardial Infarction Trial). Am J Cardiol 2001;88:1085-1090. Go to original source... Go to PubMed...
  24. Rott D, Behar S, Leor J, Hod H, Boyko V, Mandelzweig L, Gottlieb S. Effect on Survival of Acute Myocardial Infarction in Killip Classes II or III Patients Undergoing Invasive Coronary Procedures. Am J Cardiol 2001;88:618-623. Go to original source... Go to PubMed...
  25. Mehta RH, Rathore SS, Radford MJ, Wang Y, Wang Y, Krumholz HM. Acute Myocardial Infarction in the Elderly:Differences by Age. J Am Coll Cardiol 2001;38:736-741. Go to original source... Go to PubMed...
  26. Holmes Jr. DR, White HD, Pieper KS, Ellis SG, Califf RM, Topol EJ. Effect of Age on Outcome With Primary Angioplsty Versus Thrombolysis. J Am Coll Cardiol 1999;33:412-419. Go to original source... Go to PubMed...
  27. Wong SCh, Sanborn T, Sleeper LA, Webb JG, Pilchik R, Hart D et al. Angiographic Findings and Clinical Correlates in Patients With Cardiogenic Shock Complicating Acute Myocardial Infarction:A Report from the SHOCK Trial Registry. J Am Coll Cardiol 2000;36:1077-1083. Go to original source... Go to PubMed...
  28. Janoušek S, Adamková R, Tesák K, et al. Mortalita pacientů s akutním infarktem myokardu na koronární jednotce Fakultní nemocnice Brno - Bohunice. Interv Akut Kardiol 2000;1:28-31.




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.